Nibali, L, Koidou, V, Nieri, M, Barbato, L, Pagliaro, U, Cairo, F. Regenerative surgery versus access flap for the treatment of intrabony periodontal defects. A systematic review and meta‐analysis Journal of clinical periodontology. 2020; 47.
Guida, L, Annunziata, M, Belardo, S, Farina, R, Scabba, A, RTrombelli, L. Effect of Autogenous Cortical Bone Particulate in Conjunction With Enamel Matrix Derivative in the Treatment of Periodontal Intraosseous Defects. Journal of periodontology. 2007; 78(2):231-8.
Yilmaz, S, Cakar, G, Yildirim, B, Sculean, A. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. Journal of clinical periodontology. 2010; 37(6):544-50.
Bokan, I, Bill, J, Schlagenhauf, U. Primary flap closure combined with Emdogains alone or Emdogains and Cerasorbs in the treatment of intrabony defects. 2006; 33:885-93.
De Leonardis, D, Paolantonio, M. Enamel Matrix Derivative, Alone or Associated With a Synthetic Bone Substitute, in the Treatment of 1- to 2-Wall Periodontal Defects. Journal of periodontology. 2013; 84:444- 55.
Losada, M, Gonzalez, R, Garcia, AP, Santos, A, Nart, J. Treatment of Non-Contained Infrabony Defects With Enamel Matrix Derivative Alone or in Combination With Biphasic Calcium Phosphate Bone Graft: A 12-Month Randomized Controlled Clinical Trial. Journal of periodontology. 2017; 88(5):426-35.
Meyle, J, Hoffmann, T, Topoll, H, Heinz, B, Al-Machot, E, JervoeStorm, PM, et al. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. Journal of clinical periodontology. 2011; 38(7):652-60.
Sculean, A, Pietruska, M, Schwarz, F, Willershausen, B, Arweiler, N, Auschill, T. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study. Journal of clinical periodontology. 2005; 32:111-7.
Zucchelli, G, Amore, C, Montebugnoli, L, De Sanctis, M. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. Journal of periodontology. 2003; 74(12):1725-35.
Sanz, M, Herrera, D, Kebschull, M, Chapple, I, Jepsen, S, Berglundh, T, et al. Treating Periodontitis – The EFP S3 Level Clinical Practice Guideline. Journal of clinical periodontology. 2020; 47.
Annunziata, M, Piccirillo, A, Perillo, F, Cecoro, G, Nastri, L, Guida, L. Enamel Matrix Derivative and Autogenous Bone Graft for Periodontal Regeneration of Intrabony Defects in Humans: A Systematic Review and Meta-Analysis. Materials (Basel, Switzerland). 2019; 12(16).
Zhou, S, Sun, C, Huang, S, Wu, X, Zhao, Y, Pan, C, et al. Efficacy of Adjunctive Bioactive Materials in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis. BioMed research international. 2018; 2018:8670832.
Matarasso, M, Iorio-Siciliano, V, Blasi, A, Ramaglia, L, Salvi, GE, Sculean, A. Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and metaanalysis. Clinical oral investigations. 2015; 19(7):1581-93.
Aspriello, SD, Ferrante, L, Rubini, C, Piemontese, M. Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery. Clinical oral investigations. 2011; 15(2):225-32.
Ogihara, S, Tarnow, DP. Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: a randomized trial. Journal of periodontology. 2014; 85(10):1351-60.